Aemetis (AMTX) Q2 2024 earnings summary

Executive summary

• Revenue for Q2 2024 was $66.6 million, up 47.5–48% year-over-year, driven by strong performance in California Ethanol and India Biodiesel segments.

• Net loss widened to $29.2 million from $25.3 million in Q2 2023, with operating loss at $13.6 million versus $7.8–$8.7 million.

• The company continues to expand renewable natural gas (RNG), sustainable aviation fuel (SAF), and facility upgrades, including a new Solar Microgrid and MVR system.

• India Biodiesel business posted strong results, appointed a new CEO, and is advancing an IPO process.

• Positive cash flow from operations reported in all three operating businesses in Q3 2024.

Financial highlights

• Q2 2024 gross loss was $1.8 million, compared to a $2.0 million profit in Q2 2023.

• SG&A expenses rose to $11.8 million, including a $3.6 million loss on asset disposal.

• Interest expense increased to $11.7 million, with $3.5 million accretion of Series A preferred units.

• Cash balance at quarter-end was $234,000, down from $2.7 million at 2023 year-end.

• Debt at June 30, 2024 was $309.0 million, up from $294.7 million at year-end 2023.

Outlook and guidance

• Regulatory events and operational improvements are expected to drive over $50 million in annual positive cash flow starting January 2025.

• Biogas segment could deliver $50 million in positive cash flow if expected credit values materialize.

• Guidance for 16 dairy digesters online by year-end 2024, scaling RNG production run rate from 300,000 to 800,000 MMBtu/year.

• MVR system at Keyes plant targeted for Q3 2025 completion, with potential $15–$29 million annual cash flow improvement.

• India biodiesel contract renewal expected to be larger, with ongoing plant capacity expansion and IPO process underway.